Genetic susceptibility according to three metabolic pathways in cancers of the lung and bladder and in myeloid leukemias in nonsmokers.

Bibliographic Details
Title: Genetic susceptibility according to three metabolic pathways in cancers of the lung and bladder and in myeloid leukemias in nonsmokers.
Authors: P Vineis, F Veglia, S Garte, C Malaveille, G Matullo, A Dunning, M Peluso, L Airoldi, K Overvad, O Raaschou-Nielsen, F Clavel-Chapelon, JP Linseisen, R Kaaks, H Boeing, A Trichopoulou, D Palli, P Crosignani, R Tumino, S Panico, HB Bueno-De-Mesquita
Source: Annals of Oncology. Jul2007, Vol. 18 Issue 7, p1230-1230. 1p.
Subject Terms: *GENETIC polymorphisms, *NUCLEOTIDES, *GENOTYPE-environment interaction, *AIR pollution, *LUNG cancer, *BLADDER cancer, *MYELOID leukemia
Abstract: Background: We chose a set of candidate single nucleotide polymorphisms (SNPs) to investigate gene–environment interactions in three types of cancer that have been related to air pollution (lung, bladder and myeloid leukemia). Patients and methods: The study has been conducted as a nested case–control study within the European Prospective Investigation into Cancer and Nutrition cohort (409 cancer cases and 757 matched controls). We included never and ex-smokers. SNPs were in genes involved in oxidative stress, phase I metabolizing genes, phase II metabolizing genes and methylenetetrahydrofolate reductase (MTHFR). Results: The most notable findings are: GSTM1 deletion and bladder cancer risk [odds ratio (OR) = 1.60; 95% confidence interval 1.00–2.56]; CYP1A1 and leukemia (2.22, 1.33–3.70; heterozygotes); CYP1B1 and leukemia (0.47, 0.27–0.84; homozygotes); MnSOD and leukemia (1.91, 1.08–3.38; homozygotes) and NQO1 and lung cancer (8.03, 1.73–37.3; homozygotes). Other statistically significant associations were found in subgroups defined by smoking habits (never or ex-smokers), environmental tobacco smoke or gender, with no obvious pattern. When gene variants were organized according to the three main pathways, the emerging picture was of a strong involvement of combined phase I enzymes in leukemia, with an OR of 5 (1.63–15.4) for those having three or more variant alleles. The association was considerably stronger for leukemias arising before the age of 55. [ABSTRACT FROM AUTHOR]
Copyright of Annals of Oncology is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Academic Search Complete
More Details
ISSN:09237534
DOI:10.1093/annonc/mdm109
Published in:Annals of Oncology
Language:English